Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
May 22, 2007
Novel insight into the agonistic mechanism of alefacept in vivo: differentially expressed genes may serve as biomarkers of response in psoriasis patients
Asifa S Haider, Michelle A Lowes, Humphrey Gardner, et al.
British Journal of Clinical Pharmacology
|
April 27, 2025
A novel approach for first-in-human dose selection using population dose-response modelling to find a minimum anticipated biological effect level
Lin Yuan, Meghana Kulkarni, Evan Chiswick, et al.
Antimicrobial Agents and Chemotherapy
|
December 24, 2014
Characterization of the novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in Neisseria gonorrhoeae
Richard A Alm, Sushmita D Lahiri, Amy Kutschke, et al.
Pigment Cell & Melanoma Research
|
December 24, 2010
A proliferative melanoma cell phenotype is responsive to RAF/MEK inhibition independent of BRAF mutation status
Marie C Zipser, Ossia M Eichhoff, Daniel S Widmer, et al.
Pharmacogenomics
|
December 19, 2007
Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patients
Mizutomo Azuma, Michael Shi, Kathleen D Danenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 24, 2017
Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer
Toni K Choueiri, Elizabeth Plimack, Hendrik-Tobias Arkenau, et al.
Breast Cancer Research and Treatment
|
October 22, 2009
Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer
Matthew J Ellis, Li Lin, Robert Crowder, et al.
Frontiers in Cellular and Infection Microbiology
|
January 30, 2023
Development of a novel loop-mediated isothermal amplification assay for ß-lactamase gene identification using clinical isolates of Gram-negative bacteria
Eun Jin Kim, Jiwon Lee, Youngbae Yoon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2015
PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance
Howard M Stern, Humphrey Gardner, Tomasz Burzykowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2009
Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer
José Baselga, Vladimir Semiglazov, Peter van Dam, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Journal of Immunology (Baltimore, Md. : 1950)
|
May 22, 2007
Novel insight into the agonistic mechanism of alefacept in vivo: differentially expressed genes may serve as biomarkers of response in psoriasis patients
Asifa S Haider, Michelle A Lowes, Humphrey Gardner, et al.
British Journal of Clinical Pharmacology
|
April 27, 2025
A novel approach for first-in-human dose selection using population dose-response modelling to find a minimum anticipated biological effect level
Lin Yuan, Meghana Kulkarni, Evan Chiswick, et al.
Antimicrobial Agents and Chemotherapy
|
December 24, 2014
Characterization of the novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in Neisseria gonorrhoeae
Richard A Alm, Sushmita D Lahiri, Amy Kutschke, et al.
Pigment Cell & Melanoma Research
|
December 24, 2010
A proliferative melanoma cell phenotype is responsive to RAF/MEK inhibition independent of BRAF mutation status
Marie C Zipser, Ossia M Eichhoff, Daniel S Widmer, et al.
Pharmacogenomics
|
December 19, 2007
Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patients
Mizutomo Azuma, Michael Shi, Kathleen D Danenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 24, 2017
Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer
Toni K Choueiri, Elizabeth Plimack, Hendrik-Tobias Arkenau, et al.
Breast Cancer Research and Treatment
|
October 22, 2009
Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer
Matthew J Ellis, Li Lin, Robert Crowder, et al.
Frontiers in Cellular and Infection Microbiology
|
January 30, 2023
Development of a novel loop-mediated isothermal amplification assay for ß-lactamase gene identification using clinical isolates of Gram-negative bacteria
Eun Jin Kim, Jiwon Lee, Youngbae Yoon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2015
PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance
Howard M Stern, Humphrey Gardner, Tomasz Burzykowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2009
Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer
José Baselga, Vladimir Semiglazov, Peter van Dam, et al.
Page
of 6